| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 18,965 | 19,200 |
| Net increase (decrease) in cash and cash equivalents | 7,218 | 9,427 |
| Cash and cash equivalents at beginning of period | 13,552 | - |
| Cash and cash equivalents at end of period | 20,770 | - |
NeuroPace Inc (NPCE)
NeuroPace Inc (NPCE)